Moreover, celastrol reverses palmitic acid-induced insulin resistance by activating Toll-like receptor (TLR4)/myeloid differentiation factor 2 (MD2)/NF-κB signalling [66]. The gene discussed is NFKB1; the disease is Insulin resistance.